$803 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 40 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AVIR | New | ATEA PHARMACEUTICALS INC | $10,838,000 | – | 309,126 | +100.0% | 1.35% | – |
| GH | New | GUARDANT HEALTH INC | $8,751,000 | – | 70,000 | +100.0% | 1.09% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $3,072,000 | – | 38,500 | +100.0% | 0.38% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lcall | $2,168,000 | – | 80,000 | +100.0% | 0.27% | – |
| SPY | New | SPDR S&P 500 ETF TRput | $1,556,000 | – | 250,000 | +100.0% | 0.19% | – |
| VIR | New | VIR BIOTECHNOLOGY INCcall | $1,197,000 | – | 383,700 | +100.0% | 0.15% | – |
| PTIX | New | PROTAGENIC THERAPEUTICS INC | $935,000 | – | 500,000 | +100.0% | 0.12% | – |
| QQQ | New | INVESCO QQQ TRput | $895,000 | – | 300,000 | +100.0% | 0.11% | – |
| LLY | New | LILLY ELI & COcall | $680,000 | – | 100,000 | +100.0% | 0.08% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INCcall | $426,000 | – | 63,000 | +100.0% | 0.05% | – |
| XBIT | New | XBIOTECH INC | $275,000 | – | 350,000 | +100.0% | 0.03% | – |
| SEM | New | SELECT MED HLDGS CORPcall | $193,000 | – | 26,100 | +100.0% | 0.02% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INCcall | $176,000 | – | 150,000 | +100.0% | 0.02% | – |
| OPK | New | OPKO HEALTH INCcall | $145,000 | – | 473,800 | +100.0% | 0.02% | – |
| PFE | New | PFIZER INCcall | $98,000 | – | 750,000 | +100.0% | 0.01% | – |
| AGEN | New | AGENUS INCcall | $53,000 | – | 100,000 | +100.0% | 0.01% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF INcall | $50,000 | – | 43,700 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.